Is this your brand? Claim it — free, and takes a minute with your work email.

Overview

Tagline Brand's website · 2026-10-04

Uniquely addresses intercellular heterogeneity in drug repurposing by developing a drug score that considers all cell clusters from single-cell RNA sequencing data, leading to superior accuracy compared to both bulk-cell-based and other single-cell-based methods.

Description Brand's website · 2026-10-04

ASGARD is a single-cell guided pipeline designed to aid in the repurposing of drugs. It defines a drug score to recommend drugs by considering intercellular heterogeneity within each patient by leveraging single-cell RNA sequencing (scRNA-seq) data. The tool aims to identify effective drugs for heterogeneous diseases, such as cancers and COVID-19, by analyzing drug efficacy across multiple cell clusters.

Offerings

Core capabilities Brand's website · 2026-10-04

ASGARD: A Single-cell Guided Pipeline to Aid Repurposing of Drugs (computational tool)

Pricing Brand's website · 2026-10-04

Free for educational use (open-source on GitHub); commercial licensing information not provided, suggesting it's primarily an academic tool.

Audience

Target industry Brand's website · 2026-10-04

Researchers in drug discovery and development, computational biology, precision medicine, oncology, infectious diseases; academic institutions; pharmaceutical companies' R&D departments.

Landscape

Competitors Brand's website · 2026-10-04

  • Alakwaa's pipeline
  • Guo et al.'s pipeline (using Seurat and CLUE)
  • Bulk-cell based drug repurposing methods
  • Other cell cluster-level predicting methods

Is this your business?

The information above is publicly sourced — assembled by Optimly from communication-tool-repurposing's website and public pages.

Claim this profile to publish your own verified Business Profile and speak for communication-tool-repurposing across the index.

Claim communication-tool-repurposing — free →

Page last updated 2026-10-04.